Respiratory viruses: New frontiers—a Keystone Symposia report

Jennifer Cable, Jie Sun, In Su Cheon, Andrew E. Vaughan, Italo A. Castro, Sydney R. Stein, Carolina B. López, Katelyn M. Gostic, Peter J.M. Openshaw, Ali H. Ellebedy, Andreas Wack, Edward Hutchinson, Mallory M. Thomas, Ryan A. Langlois, Daniel Lingwood, Steven F. Baker, Melanie Folkins, Ellen F. Foxman, Andrew B. Ward, Martin SchwemmleAlistair B. Russell, Christopher Chiu, Ketaki Ganti, Kanta Subbarao, Timothy P. Sheahan, Pablo Penaloza-MacMaster, Taylor Eddens

Research output: Contribution to journalArticlepeer-review


Respiratory viruses are a common cause of morbidity and mortality around the world. Viruses like influenza, RSV, and most recently SARS-CoV-2 can rapidly spread through a population, causing acute infection and, in vulnerable populations, severe or chronic disease. Developing effective treatment and prevention strategies often becomes a race against ever-evolving viruses that develop resistance, leaving therapy efficacy either short-lived or relevant for specific viral strains. On June 29 to July 2, 2022, researchers met for the Keystone symposium “Respiratory Viruses: New Frontiers.” Researchers presented new insights into viral biology and virus–host interactions to understand the mechanisms of disease and identify novel treatment and prevention approaches that are effective, durable, and broad.

Original languageEnglish
Pages (from-to)60-73
Number of pages14
JournalAnnals of the New York Academy of Sciences
Issue number1
StatePublished - Apr 2023


  • COVID-19
  • RSV
  • adaptive immunity
  • influenza virus
  • innate immunity
  • respiratory virus


Dive into the research topics of 'Respiratory viruses: New frontiers—a Keystone Symposia report'. Together they form a unique fingerprint.

Cite this